Danaher (NYSE:DHR) Price Target Raised to $270.00 at The Goldman Sachs Group

Danaher (NYSE:DHR) had its price target raised by The Goldman Sachs Group from $265.00 to $270.00 in a research note issued to investors on Tuesday,MarketScreener reports. The brokerage currently has a buy rating on the conglomerate’s stock.

DHR has been the subject of several other reports. Redburn Partners set a $220.00 target price on Danaher in a research report on Wednesday, October 8th. Jefferies Financial Group increased their price objective on shares of Danaher from $245.00 to $255.00 and gave the stock a “buy” rating in a research report on Wednesday, December 17th. Evercore ISI reiterated an “outperform” rating and issued a $250.00 price objective on shares of Danaher in a research note on Monday, January 5th. Rothschild & Co Redburn reissued a “neutral” rating and set a $220.00 target price (down from $245.00) on shares of Danaher in a research note on Wednesday, October 8th. Finally, HSBC lifted their price target on shares of Danaher from $255.00 to $270.00 and gave the company a “buy” rating in a research note on Monday, December 1st. Twenty-one equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $252.09.

Danaher Stock Performance

Shares of NYSE DHR traded up $2.76 during trading hours on Tuesday, reaching $237.09. 739,758 shares of the stock were exchanged, compared to its average volume of 2,966,395. Danaher has a 52 week low of $171.00 and a 52 week high of $258.23. The firm has a market capitalization of $167.46 billion, a price-to-earnings ratio of 48.92, a P/E/G ratio of 4.20 and a beta of 0.89. The stock’s fifty day simple moving average is $229.17 and its 200 day simple moving average is $212.44. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.10 and a current ratio of 1.52.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Monday, October 20th. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.72 by $0.17. The firm had revenue of $6.05 billion for the quarter, compared to the consensus estimate of $6 billion. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The business’s revenue for the quarter was up 4.4% on a year-over-year basis. During the same period in the prior year, the company posted $1.71 earnings per share. Sell-side analysts predict that Danaher will post 7.63 EPS for the current year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be paid a $0.32 dividend. The ex-dividend date of this dividend is Friday, December 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.5%. Danaher’s dividend payout ratio is currently 26.39%.

Insider Buying and Selling at Danaher

In other news, Director Teri List sold 3,298 shares of Danaher stock in a transaction that occurred on Tuesday, November 18th. The shares were sold at an average price of $226.50, for a total transaction of $746,997.00. Following the completion of the sale, the director owned 20,762 shares of the company’s stock, valued at approximately $4,702,593. The trade was a 13.71% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP Brian W. Ellis sold 21,776 shares of the company’s stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $219.23, for a total value of $4,773,952.48. Following the completion of the sale, the senior vice president owned 14,553 shares of the company’s stock, valued at $3,190,454.19. This represents a 59.94% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 30,248 shares of company stock worth $6,609,663 over the last 90 days. Company insiders own 11.20% of the company’s stock.

Institutional Trading of Danaher

A number of institutional investors have recently modified their holdings of the company. JPL Wealth Management LLC purchased a new stake in shares of Danaher during the third quarter valued at $25,000. WFA of San Diego LLC acquired a new position in shares of Danaher in the second quarter valued at about $26,000. ANTIPODES PARTNERS Ltd purchased a new position in shares of Danaher in the third quarter worth about $27,000. Howard Hughes Medical Institute acquired a new stake in shares of Danaher during the second quarter worth about $27,000. Finally, TruNorth Capital Management LLC acquired a new position in Danaher in the 3rd quarter worth approximately $28,000. 79.05% of the stock is currently owned by institutional investors.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.